Monounsaturated fatty acid · Joint support compound

Cetyl myristoleate,
the joint lipid,
explained plainly.

A naturally derived monounsaturated fatty acid studied for its role in helping cushion and lubricate joints — and the science most supplement labels never bother to explain.

The short version

Most joint supplements borrow from the same short list. This one works differently.

Cetyl myristoleate (sometimes written CMO, and used in branded form as CM8®) is the cetyl ester of myristoleic acid. Rather than acting as a building block the way glucosamine does, it behaves like a lipid — the category of the body’s own joint-cushioning and lubricating chemistry. Below is the honest, plain-language breakdown.

01

A fatty acid, not a sugar

Glucosamine and chondroitin are sugar-based compounds. Cetyl myristoleate is a fatty acid ester — it sits in the same lipid family as the substances that help keep joint surfaces slick and cushioned.

02

Monounsaturated by structure

One double bond defines it. That single point of unsaturation puts it alongside olive oil chemically, and apart from the polyunsaturated profile of fish-oil omega-3s — a distinction with real implications.

03

Studied for comfort & mobility

Early clinical work explored cetyl myristoleate for joint comfort and range of motion. We summarize what those studies actually measured — and what they didn’t — on the research page.

Grounded in the literature

We cite the studies, and we read the fine print.

Cetyl myristoleate first drew attention through joint-comfort research in the late 1990s. We lay out the key studies, their sample sizes, and their limits — so you can judge the evidence yourself instead of taking a label’s word for it.

Read the research summary

1990sFirst peer-reviewed joint-comfort studies on cetyl myristoleate
C16:C14:1Cetyl (saturated) ester of myristoleic (monounsaturated) acid